1 s Disease', was held at the Arnold and Mabel Beckman Center in Irvine, California.

2 te AMD, and late AMD graded according to the Beckman clinical classification system.

3 he results were correlated to the commercial Beckman Colter, Hybritech immunoassay(R) for determinati

4 rogen ChargeSwitch-Pro PCR Purification, and Beckman Coulter AMPure XP.

5 Assay for use on the new and fully automated Beckman Coulter DxN Veris Molecular Diagnostics System (

6 -1 assay for use on the new, fully automated Beckman Coulter DxN Veris molecular diagnostics system w

7          BD Phoenix, bioMerieux Vitek 2, and Beckman Coulter MicroScan commercial automated susceptib

8 es fixed in osmium tetroxide and analyzed by Beckman Coulter Multisizer.

9                 In this method, the Vi-CELL (Beckman Coulter) was used to measure cell diameter chang

10 ed to microparticle size analysis (RapidVue, Beckman Coulter).

11 copy every 10 years, annual Hemoccult SENSA (Beckman Coulter, Fullerton, California) testing or fecal

12 l blood cards (Hemoccult and HemoccultSensa, Beckman Coulter, Fullerton, California) were tested on 3

13 gh, MA), Hemoccult, and HemoccultSensa (both Beckman-Coulter, Fullerton, CA).

14 assays (hs-cTnT, Roche Diagnostics; hs-cTnI, Beckman-Coulter; hs-cTnI Siemens) in a blinded fashion a

15 e Boltzmann transport equation and using the Beckman-Kirchhoff surface scattering theory with shadowi

16 t the University of California-Irvine Health Beckman Laser Institute & Medical Clinic, Irvine, betwee

17 c ketones that are converted to imines via a Beckman rearrangement reaction.

18 g factors, were centrifuged at 3000 rpm in a Beckman Sanderson Chamber.

19 alibrate quality values that come along with Beckman sequencers.